Ikena Oncology, Inc. (IKNA) Financials

IKNA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 192.1 million 22.3 million
2023-09-30 215.3 million 60.0 million
2023-06-30 171.8 million 15.1 million
2023-03-31 152.4 million 17.4 million

IKNA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -22.1 million 1.8 million
2023-09-30 -20.0 million 2.0 million
2023-06-30 -18.1 million 1.9 million
2023-03-31 -19.9 million 2.0 million

IKNA Net Income

No data available :(

IKNA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 175.5 million - 10.7 million
2023-09-30 196.9 million - 11.5 million
2023-06-30 157.3 million - 5.0 million
2023-03-31 137.8 million - 5.3 million

IKNA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 47.8 million
2023-09-30 43.4 million
2023-06-30 39.3 million
2023-03-31 36.3 million

IKNA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 262000 14.0 million 8.3 million 1
2023-09-30 - 1.2 million 6.0 million -
2023-06-30 4000 15.2 million 5.3 million -
2023-03-31 152000 15.6 million 5.3 million -

IKNA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 659000 305000
2023-09-30 1.2 million 242000
2023-06-30 2.0 million 586000
2023-03-31 5.3 million 568000

IKNA

Price: $1.30

52 week price:
1.02
7.64

Earnings Per Share: -1.63 USD

P/E Ratio: -0.93

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 7489

Market Capitalization: 61.3 million

Links: